Cargando…

SAR Studies Leading to the Identification of a Novel Series of Metallo-β-lactamase Inhibitors for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections That Display Efficacy in an Animal Infection Model

[Image: see text] The clinical effectiveness of carbapenem antibiotics such as meropenem is becoming increasingly compromised by the spread of both metallo-β-lactamase (MBL) and serine-β-lactamase (SBL) enzymes on mobile genetic elements, stimulating research to find new β-lactamase inhibitors to be...

Descripción completa

Detalles Bibliográficos
Autores principales: Leiris, Simon, Coelho, Alicia, Castandet, Jérôme, Bayet, Maëlle, Lozano, Clarisse, Bougnon, Juliette, Bousquet, Justine, Everett, Martin, Lemonnier, Marc, Sprynski, Nicolas, Zalacain, Magdalena, Pallin, Thomas David, Cramp, Michael C., Jennings, Neil, Raphy, Gilles, Jones, Mark W., Pattipati, Ramesh, Shankar, Battu, Sivasubrahmanyam, Relangi, Soodhagani, Ashok K., Juventhala, Ramakrishna R., Pottabathini, Narender, Pothukanuri, Srinivasu, Benvenuti, Manuela, Pozzi, Cecilia, Mangani, Stefano, De Luca, Filomena, Cerboni, Giulia, Docquier, Jean-Denis, Davies, David T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2018
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332448/
https://www.ncbi.nlm.nih.gov/pubmed/30427656
http://dx.doi.org/10.1021/acsinfecdis.8b00246
_version_ 1783387353195216896
author Leiris, Simon
Coelho, Alicia
Castandet, Jérôme
Bayet, Maëlle
Lozano, Clarisse
Bougnon, Juliette
Bousquet, Justine
Everett, Martin
Lemonnier, Marc
Sprynski, Nicolas
Zalacain, Magdalena
Pallin, Thomas David
Cramp, Michael C.
Jennings, Neil
Raphy, Gilles
Jones, Mark W.
Pattipati, Ramesh
Shankar, Battu
Sivasubrahmanyam, Relangi
Soodhagani, Ashok K.
Juventhala, Ramakrishna R.
Pottabathini, Narender
Pothukanuri, Srinivasu
Benvenuti, Manuela
Pozzi, Cecilia
Mangani, Stefano
De Luca, Filomena
Cerboni, Giulia
Docquier, Jean-Denis
Davies, David T.
author_facet Leiris, Simon
Coelho, Alicia
Castandet, Jérôme
Bayet, Maëlle
Lozano, Clarisse
Bougnon, Juliette
Bousquet, Justine
Everett, Martin
Lemonnier, Marc
Sprynski, Nicolas
Zalacain, Magdalena
Pallin, Thomas David
Cramp, Michael C.
Jennings, Neil
Raphy, Gilles
Jones, Mark W.
Pattipati, Ramesh
Shankar, Battu
Sivasubrahmanyam, Relangi
Soodhagani, Ashok K.
Juventhala, Ramakrishna R.
Pottabathini, Narender
Pothukanuri, Srinivasu
Benvenuti, Manuela
Pozzi, Cecilia
Mangani, Stefano
De Luca, Filomena
Cerboni, Giulia
Docquier, Jean-Denis
Davies, David T.
author_sort Leiris, Simon
collection PubMed
description [Image: see text] The clinical effectiveness of carbapenem antibiotics such as meropenem is becoming increasingly compromised by the spread of both metallo-β-lactamase (MBL) and serine-β-lactamase (SBL) enzymes on mobile genetic elements, stimulating research to find new β-lactamase inhibitors to be used in conjunction with carbapenems and other β-lactam antibiotics. Herein, we describe our initial exploration of a novel chemical series of metallo-β-lactamase inhibitors, from concept to efficacy, in a survival model using an advanced tool compound (ANT431) in conjunction with meropenem.
format Online
Article
Text
id pubmed-6332448
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-63324482019-01-17 SAR Studies Leading to the Identification of a Novel Series of Metallo-β-lactamase Inhibitors for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections That Display Efficacy in an Animal Infection Model Leiris, Simon Coelho, Alicia Castandet, Jérôme Bayet, Maëlle Lozano, Clarisse Bougnon, Juliette Bousquet, Justine Everett, Martin Lemonnier, Marc Sprynski, Nicolas Zalacain, Magdalena Pallin, Thomas David Cramp, Michael C. Jennings, Neil Raphy, Gilles Jones, Mark W. Pattipati, Ramesh Shankar, Battu Sivasubrahmanyam, Relangi Soodhagani, Ashok K. Juventhala, Ramakrishna R. Pottabathini, Narender Pothukanuri, Srinivasu Benvenuti, Manuela Pozzi, Cecilia Mangani, Stefano De Luca, Filomena Cerboni, Giulia Docquier, Jean-Denis Davies, David T. ACS Infect Dis [Image: see text] The clinical effectiveness of carbapenem antibiotics such as meropenem is becoming increasingly compromised by the spread of both metallo-β-lactamase (MBL) and serine-β-lactamase (SBL) enzymes on mobile genetic elements, stimulating research to find new β-lactamase inhibitors to be used in conjunction with carbapenems and other β-lactam antibiotics. Herein, we describe our initial exploration of a novel chemical series of metallo-β-lactamase inhibitors, from concept to efficacy, in a survival model using an advanced tool compound (ANT431) in conjunction with meropenem. American Chemical Society 2018-11-14 2019-01-11 /pmc/articles/PMC6332448/ /pubmed/30427656 http://dx.doi.org/10.1021/acsinfecdis.8b00246 Text en Copyright © 2018 American Chemical Society This is an open access article published under a Creative Commons Attribution (CC-BY) License (http://pubs.acs.org/page/policy/authorchoice_ccby_termsofuse.html) , which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited.
spellingShingle Leiris, Simon
Coelho, Alicia
Castandet, Jérôme
Bayet, Maëlle
Lozano, Clarisse
Bougnon, Juliette
Bousquet, Justine
Everett, Martin
Lemonnier, Marc
Sprynski, Nicolas
Zalacain, Magdalena
Pallin, Thomas David
Cramp, Michael C.
Jennings, Neil
Raphy, Gilles
Jones, Mark W.
Pattipati, Ramesh
Shankar, Battu
Sivasubrahmanyam, Relangi
Soodhagani, Ashok K.
Juventhala, Ramakrishna R.
Pottabathini, Narender
Pothukanuri, Srinivasu
Benvenuti, Manuela
Pozzi, Cecilia
Mangani, Stefano
De Luca, Filomena
Cerboni, Giulia
Docquier, Jean-Denis
Davies, David T.
SAR Studies Leading to the Identification of a Novel Series of Metallo-β-lactamase Inhibitors for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections That Display Efficacy in an Animal Infection Model
title SAR Studies Leading to the Identification of a Novel Series of Metallo-β-lactamase Inhibitors for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections That Display Efficacy in an Animal Infection Model
title_full SAR Studies Leading to the Identification of a Novel Series of Metallo-β-lactamase Inhibitors for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections That Display Efficacy in an Animal Infection Model
title_fullStr SAR Studies Leading to the Identification of a Novel Series of Metallo-β-lactamase Inhibitors for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections That Display Efficacy in an Animal Infection Model
title_full_unstemmed SAR Studies Leading to the Identification of a Novel Series of Metallo-β-lactamase Inhibitors for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections That Display Efficacy in an Animal Infection Model
title_short SAR Studies Leading to the Identification of a Novel Series of Metallo-β-lactamase Inhibitors for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections That Display Efficacy in an Animal Infection Model
title_sort sar studies leading to the identification of a novel series of metallo-β-lactamase inhibitors for the treatment of carbapenem-resistant enterobacteriaceae infections that display efficacy in an animal infection model
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332448/
https://www.ncbi.nlm.nih.gov/pubmed/30427656
http://dx.doi.org/10.1021/acsinfecdis.8b00246
work_keys_str_mv AT leirissimon sarstudiesleadingtotheidentificationofanovelseriesofmetalloblactamaseinhibitorsforthetreatmentofcarbapenemresistantenterobacteriaceaeinfectionsthatdisplayefficacyinananimalinfectionmodel
AT coelhoalicia sarstudiesleadingtotheidentificationofanovelseriesofmetalloblactamaseinhibitorsforthetreatmentofcarbapenemresistantenterobacteriaceaeinfectionsthatdisplayefficacyinananimalinfectionmodel
AT castandetjerome sarstudiesleadingtotheidentificationofanovelseriesofmetalloblactamaseinhibitorsforthetreatmentofcarbapenemresistantenterobacteriaceaeinfectionsthatdisplayefficacyinananimalinfectionmodel
AT bayetmaelle sarstudiesleadingtotheidentificationofanovelseriesofmetalloblactamaseinhibitorsforthetreatmentofcarbapenemresistantenterobacteriaceaeinfectionsthatdisplayefficacyinananimalinfectionmodel
AT lozanoclarisse sarstudiesleadingtotheidentificationofanovelseriesofmetalloblactamaseinhibitorsforthetreatmentofcarbapenemresistantenterobacteriaceaeinfectionsthatdisplayefficacyinananimalinfectionmodel
AT bougnonjuliette sarstudiesleadingtotheidentificationofanovelseriesofmetalloblactamaseinhibitorsforthetreatmentofcarbapenemresistantenterobacteriaceaeinfectionsthatdisplayefficacyinananimalinfectionmodel
AT bousquetjustine sarstudiesleadingtotheidentificationofanovelseriesofmetalloblactamaseinhibitorsforthetreatmentofcarbapenemresistantenterobacteriaceaeinfectionsthatdisplayefficacyinananimalinfectionmodel
AT everettmartin sarstudiesleadingtotheidentificationofanovelseriesofmetalloblactamaseinhibitorsforthetreatmentofcarbapenemresistantenterobacteriaceaeinfectionsthatdisplayefficacyinananimalinfectionmodel
AT lemonniermarc sarstudiesleadingtotheidentificationofanovelseriesofmetalloblactamaseinhibitorsforthetreatmentofcarbapenemresistantenterobacteriaceaeinfectionsthatdisplayefficacyinananimalinfectionmodel
AT sprynskinicolas sarstudiesleadingtotheidentificationofanovelseriesofmetalloblactamaseinhibitorsforthetreatmentofcarbapenemresistantenterobacteriaceaeinfectionsthatdisplayefficacyinananimalinfectionmodel
AT zalacainmagdalena sarstudiesleadingtotheidentificationofanovelseriesofmetalloblactamaseinhibitorsforthetreatmentofcarbapenemresistantenterobacteriaceaeinfectionsthatdisplayefficacyinananimalinfectionmodel
AT pallinthomasdavid sarstudiesleadingtotheidentificationofanovelseriesofmetalloblactamaseinhibitorsforthetreatmentofcarbapenemresistantenterobacteriaceaeinfectionsthatdisplayefficacyinananimalinfectionmodel
AT crampmichaelc sarstudiesleadingtotheidentificationofanovelseriesofmetalloblactamaseinhibitorsforthetreatmentofcarbapenemresistantenterobacteriaceaeinfectionsthatdisplayefficacyinananimalinfectionmodel
AT jenningsneil sarstudiesleadingtotheidentificationofanovelseriesofmetalloblactamaseinhibitorsforthetreatmentofcarbapenemresistantenterobacteriaceaeinfectionsthatdisplayefficacyinananimalinfectionmodel
AT raphygilles sarstudiesleadingtotheidentificationofanovelseriesofmetalloblactamaseinhibitorsforthetreatmentofcarbapenemresistantenterobacteriaceaeinfectionsthatdisplayefficacyinananimalinfectionmodel
AT jonesmarkw sarstudiesleadingtotheidentificationofanovelseriesofmetalloblactamaseinhibitorsforthetreatmentofcarbapenemresistantenterobacteriaceaeinfectionsthatdisplayefficacyinananimalinfectionmodel
AT pattipatiramesh sarstudiesleadingtotheidentificationofanovelseriesofmetalloblactamaseinhibitorsforthetreatmentofcarbapenemresistantenterobacteriaceaeinfectionsthatdisplayefficacyinananimalinfectionmodel
AT shankarbattu sarstudiesleadingtotheidentificationofanovelseriesofmetalloblactamaseinhibitorsforthetreatmentofcarbapenemresistantenterobacteriaceaeinfectionsthatdisplayefficacyinananimalinfectionmodel
AT sivasubrahmanyamrelangi sarstudiesleadingtotheidentificationofanovelseriesofmetalloblactamaseinhibitorsforthetreatmentofcarbapenemresistantenterobacteriaceaeinfectionsthatdisplayefficacyinananimalinfectionmodel
AT soodhaganiashokk sarstudiesleadingtotheidentificationofanovelseriesofmetalloblactamaseinhibitorsforthetreatmentofcarbapenemresistantenterobacteriaceaeinfectionsthatdisplayefficacyinananimalinfectionmodel
AT juventhalaramakrishnar sarstudiesleadingtotheidentificationofanovelseriesofmetalloblactamaseinhibitorsforthetreatmentofcarbapenemresistantenterobacteriaceaeinfectionsthatdisplayefficacyinananimalinfectionmodel
AT pottabathininarender sarstudiesleadingtotheidentificationofanovelseriesofmetalloblactamaseinhibitorsforthetreatmentofcarbapenemresistantenterobacteriaceaeinfectionsthatdisplayefficacyinananimalinfectionmodel
AT pothukanurisrinivasu sarstudiesleadingtotheidentificationofanovelseriesofmetalloblactamaseinhibitorsforthetreatmentofcarbapenemresistantenterobacteriaceaeinfectionsthatdisplayefficacyinananimalinfectionmodel
AT benvenutimanuela sarstudiesleadingtotheidentificationofanovelseriesofmetalloblactamaseinhibitorsforthetreatmentofcarbapenemresistantenterobacteriaceaeinfectionsthatdisplayefficacyinananimalinfectionmodel
AT pozzicecilia sarstudiesleadingtotheidentificationofanovelseriesofmetalloblactamaseinhibitorsforthetreatmentofcarbapenemresistantenterobacteriaceaeinfectionsthatdisplayefficacyinananimalinfectionmodel
AT manganistefano sarstudiesleadingtotheidentificationofanovelseriesofmetalloblactamaseinhibitorsforthetreatmentofcarbapenemresistantenterobacteriaceaeinfectionsthatdisplayefficacyinananimalinfectionmodel
AT delucafilomena sarstudiesleadingtotheidentificationofanovelseriesofmetalloblactamaseinhibitorsforthetreatmentofcarbapenemresistantenterobacteriaceaeinfectionsthatdisplayefficacyinananimalinfectionmodel
AT cerbonigiulia sarstudiesleadingtotheidentificationofanovelseriesofmetalloblactamaseinhibitorsforthetreatmentofcarbapenemresistantenterobacteriaceaeinfectionsthatdisplayefficacyinananimalinfectionmodel
AT docquierjeandenis sarstudiesleadingtotheidentificationofanovelseriesofmetalloblactamaseinhibitorsforthetreatmentofcarbapenemresistantenterobacteriaceaeinfectionsthatdisplayefficacyinananimalinfectionmodel
AT daviesdavidt sarstudiesleadingtotheidentificationofanovelseriesofmetalloblactamaseinhibitorsforthetreatmentofcarbapenemresistantenterobacteriaceaeinfectionsthatdisplayefficacyinananimalinfectionmodel